Prospective WCD Post CABG Registry
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The primary objective is to observe the rate of recovery of ventricular function (EF\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Patient underwent first-time CABG surgery \<10 days before enrollment.
• Patient is prescribed WCD for a primary reason of HF with reduced EF \< 35% measured after surgery but before hospital discharge.
• Patient is ≥18 years old
Locations
Other Locations
Germany
Kerckhoff Klinik
NOT_YET_RECRUITING
Bad Nauheim
Sana-Herzzentrum Cottbus GmbH
RECRUITING
Cottbus
Universitätsklinikum Halle (Saale)
RECRUITING
Halle
Medizinische Hochschule Hannover
RECRUITING
Hanover
Contact Information
Primary
Lars Weber, M.Sc.
lweber@zoll.com
015161140498
Backup
Horst-O. Esser
hesser@zoll.com
Time Frame
Start Date: 2024-09-23
Estimated Completion Date: 2030-05
Participants
Target number of participants: 910
Related Therapeutic Areas
Sponsors
Leads: Zoll Medical Corporation